https://www.mdedge.com/content/abatacept-promising-treatment-refractory-uveitis-jia-0
Abatacept Promising for Treatment-Refractory Uveitis in JIA | MDedge
abataceptpromisingtreatmentrefractoryuveitis
https://www.hss.edu/research/clinical-trials/vasculitis-abatacept-granulomatosis-polyangiitis-wegeners-abrogate
Abatacept (CTLA4-lg) for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis...
https://pmc.ncbi.nlm.nih.gov/articles/PMC5378642/
A RANDOMIZED, DOUBLE-BLIND TRIAL OF ABATACEPT (CTLA4-IG) FOR THE TREATMENT OF GIANT CELL ARTERITIS...
To compare the efficacy of abatacept to placebo for giant cell arteritis (GCA). In this multicenter trial, patients with newly-diagnosed or relapsing GCA were...
https://www.sciencedaily.com/releases/2010/09/100928111246.htm
Abatacept found ineffective in treatment of non-life threatening lupus, trial results show |...
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic...
https://stanfordhealthcare.org/trials/a/NCT02161406.html
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
a studysubcutaneousabatacept
https://pmc.ncbi.nlm.nih.gov/articles/PMC11609992/
Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for...
In rheumatoid arthritis (RA), seropositivity for both anticitrullinated protein antibody (ACPA) and rheumatoid factor (RF) is associated with disease severity...
real world clinical
https://www.fda.gov/advisory-committees/pediatric-advisory-committee/orencia-abatacept
Orencia (abatacept) | FDA
Briefing Materials for the September 15, 2020, Meeting of the Pediatric Advisory Committee. Products: Adzenys ER, Mydayis, Orencia, Vyvanse, Gamunex-C, and...
orenciaabataceptfda
https://www.dukehealth.org/clinical-trials/directory/pro00116015
HMCT/CT2401: Abatacept GVHD... | Clinical Trials at Duke
If you choose to join this study, you will start the study regimen shortly before you get your omidubicel transplant. | View the details of this clinical trial.
clinical trialsabataceptgvhdduke
https://www.hss.edu/research/clinical-trials/abatacept-vasculitis-rheumatology
Abatacept in Large Vessel Vasculitis
abataceptlargevesselvasculitis
https://www.mdedge.com/content/abatacept-promising-treatment-refractory-uveitis-jia
Abatacept Promising for Treatment-Refractory Uveitis in JIA | MDedge
abataceptpromisingtreatmentrefractoryuveitis
https://www.uclahealth.org/clinical-trials/abatacept-immune-checkpoint-inhibitor-myocarditis
Other Cancer UCLA Clinical Trial | Abatacept in Immune Checkpoint Inhibitor Myocarditis | UCLA...
immune checkpoint inhibitorclinical trialcancerucla